Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study-Reference-Cited by-同舟云学术

Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

Published:2017-08-01 Issue:10 Volume:96 Page:1693-1698
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Jurczyszyn Artur,Gozzetti Alessandro,Gdula-Argasińska Joanna,Czepiel Jacek,Vij Ravi,Fiala Mark,Valls Davila Julio,Mądry Krzysztof,Waszczuk-Gajda Anna,Grosicki Sebastian,Barchnicka Agnieszka,Crusoe Edvan,Hungria Vania,Gentile Massimo,Mele Giuseppe,Ksieniewicz Marcin,Vesole David H.,Castillo Jorge J.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3084-9/fulltext.html

Reference16 articles.

1. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538–e548. doi: 10.1016/S1470-2045(14)70442-5

2. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV (2014) Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28(5):1122–1128. doi: 10.1038/leu.2013.313

3. Rajkumar SV (2016) Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91(7):719–734. doi: 10.1002/ajh.24402

4. Wadhera RK, Kyle RA, Larson DR, Dispenzieri A, Kumar S, Lazarus HM, Rajkumar SV (2011) Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma. Blood 118(11):2985–2987. doi: 10.1182/blood-2011-04-349175

5. Graziani MS, Lippi U (1986) Multiple myeloma with serum IgM kappa and Bence Jones lambda biclonal gammopathy. Clin Chem 32(12):2220–2221

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligoclonal gammopathy: An analysis of 253 cases;Advances in Clinical and Experimental Medicine;2023-06-21

2. The effect of paraprotein polymerisation on quantitation by capillary zone electrophoresis and Hevylite®;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;2021-07-04

3. Resistance mechanisms to immune checkpoints blockade by monoclonal antibody drugs in cancer immunotherapy: Focus on myeloma;Journal of Cellular Physiology;2020-06-27

4. Biclonal myeloma in renal failure;Central European Journal of Immunology;2020

5. Epidemiology and etiopathogenesis of multiple myeloma and monoclonal gammapathy of undetermined significance;Postępy Higieny i Medycyny Doświadczalnej;2018-11-09